Amprius Technologies Reports Strong 2025 Revenue Growth, Gross Profit Turnaround, and Strategic Manufacturing Shift
AMPX has more than doubled off its 52-week low of $1.7 on elevated volume (3.0× avg).
Summary
Amprius Technologies' 2025 10-K reveals substantial revenue growth and a return to gross profitability, alongside a strategic shift to contract manufacturing and the completion of a $100 million equity offering, providing a clearer path for scaling and liquidity.
Key Events · Earnings and Guidance · AMPX
-
Strong Revenue Growth
Amprius Technologies reported a 202% increase in revenue to $73.0 million for the fiscal year 2025, driven by increased sales of SiCore batteries.
-
Gross Profit Turnaround
The company achieved a gross profit of $8.3 million in 2025, a significant improvement from a gross loss of $18.3 million in 2024.
-
Strategic Manufacturing Pivot
Amprius terminated its planned GWh-scale manufacturing facility lease in Brighton, Colorado, incurring a $19.1 million impairment charge in 2025, and will make a $20.0 million termination payment in Q1 2026. This shifts focus to a contract manufacturing strategy for rapid capacity expansion.
-
Completed $100M Equity Offering
The company successfully completed its At-The-Market (ATM) equity offering, raising cumulative net proceeds of $97.5 million by December 31, 2025, significantly enhancing liquidity.
Analysis · AMPX · Manufacturing
The 10-K filing confirms Amprius Technologies' robust financial performance in 2025, marked by a significant 202% increase in revenue and a shift from a gross loss to a gross profit. This indicates strong market traction for its silicon anode batteries. A key strategic pivot involves terminating the large Brighton, Colorado manufacturing facility lease for a $20.0 million payment in Q1 2026, opting instead for a contract manufacturing model and expanding its Fremont pilot line. This move aims for rapid capacity expansion with minimal capital investment. The company also successfully completed a $100.0 million At-The-Market (ATM) equity offering, bolstering its cash position. Dr. Kang Sun transitioned from CEO to Executive Advisor, effective January 1, 2026, with Thomas M. Stepien now serving as CEO, marking a notable executive change. While the company continues to incur net losses, these developments highlight operational improvements and a clear path for scaling production and securing liquidity.
At the time of this filing, AMPX was trading at $16.33 on NYSE in the Manufacturing sector, with a market capitalization of approximately $2.1B. The 52-week trading range was $1.70 to $17.29. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.